Is the Chinese name of Sparsentan is Sparsentan/Sparsentan?

The Chinese name of Sparsentan is usually called "Sparsentan" or "Sparsentan". Since Sparsentan is not yet on the market in China, these two names are transliterated names and may be used interchangeably in different articles, but they refer to the same drug. Sparsentan is a new type of drug for the treatment of kidney diseases. It is mainly used in the management of primary immunoglobulin in adultsA nephropathy. Its mechanism of action is different from traditional single-target drugs, giving it certain advantages in clinical practice.

As a dual inhibitor, sparsentan's unique mechanism of action allows it to simultaneously target two important bioactive substances, angiotensin II and endothelin-1. Angiotensin II is a potent vasoconstrictor involved in a variety of physiological processes, including the regulation of blood pressure and fluid balance. Among the pathogenesis of many cardiovascular and renal diseases, excessive activation of angiotensin II often leads to hypertension, proteinuria, and chronic renal damage. Endothelin-1 is a powerful contractile agent secreted by endothelial cells. Its elevation is often related to renal fibrosis and inflammatory response, further aggravating kidney damage. By blocking both receptors, sparsentane can effectively reduce urinary protein excretion, improve kidney function, and slow disease progression.

The safety and efficacy of sparsentane have been demonstrated in clinical studies. Compared with traditional single-mechanism drugs, it provides new hope for patients who do not respond well to single treatments. However, despite the promising therapeutic effects of sparsentane, there are still concerns about potential adverse effects when using it. Low blood pressure, a sharp decline in kidney function, and electrolyte imbalances are all risks that need to be monitored. Therefore, doctors need to carefully assess the patient's overall condition when prescribing and conduct regular follow-up visits to ensure the safety and effectiveness of the medication.

Reference materials:https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d7354af1-f304-f4d9-e053-2995a90ab219